Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/31386
Title: | CDP-choline modulates matrix metalloproteinases in rat sciatic injury |
Authors: | Uludağ Üniversitesi/Tıp Fakültesi/Nöroşirürji Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Eczacılık Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Anatomi Anabilim Dalı. 0000-0002-9140-4195 0000-0001-8309-0934 0000-0003-2918-5064 Gündoğdu, Elif Başaran Bekar, Ahmet Türkyılmaz, Mesut Gümüş, Abdullah Kafa, İlker Mustafa Cansev, Mehmet AAG-7125-2021 M-9071-2019 57016583400 6603677218 56320252500 56473463900 8450193200 8872816100 |
Keywords: | Surgery CDP-choline Sciatic nerve injury Matrix metalloproteinase Tissue inhibitors of metalloproteinases Axonal regeneration Neuroprotection Peripheral-nerve surgery Functional recovery Extracellular-matrix Regeneration Cytidine Model Metabolites Expression System Involvement |
Issue Date: | 1-Oct-2015 |
Publisher: | Elsevier |
Citation: | Gündoğdu, E. B. vd. (2016). "CDP-choline modulates matrix metalloproteinases in rat sciatic injury". Journal of Surgical Research, 200(2), 655-663. |
Abstract: | Background: CDP-choline (cytidine-5'-diphosphocholine) improves functional recovery, promotes nerve regeneration, and decreases perineural scarring in rat peripheral nerve injury. The aim of the present study was to investigate the mechanism of action of CDPcholine with regard to matrix metalloproteinase (MMP) activity in the rat-transected sciatic nerve injury model. Materials and methods: Male Wistar rats were randomized into Sham, Saline, and CDPcholine groups. Rats in Sham group received Sham surgery, whereas rats in Saline and CDP-choline groups underwent right sciatic nerve transection followed by immediate primary saturation and injected intraperitoneally with 0.9% NaCl (1 mL/kg) and CDP-choline (600 mg/kg), respectively. Sciatic nerve samples were obtained 1, 3, and 7 d after the surgery and analyzed for levels and activities of MMP-2 and MMP-9, levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) and TIMP-3, and axonal regeneration. Results: CDP-choline treatment decreased the levels and activities of MMP-2 and MMP-9, whereas increasing levels of TIMP-1 and TIMP-3 significantly on the third and seventh day after injury compared to Saline group. In addition, CDP-choline administration resulted in new axon formation and formation and advancement of myelination on newly formed islets (compartments) of axonal regrowth. Conclusions: Our data show, for the first time, that CDP-choline modulates MMP activity and promotes the expression of TIMPs to stimulate axonal regeneration. These data help to explain one mechanism by which CDP-choline provides neuroprotection in peripheral nerve injury. |
URI: | https://doi.org/10.1016/j.jss.2015.10.003 https://www.sciencedirect.com/science/article/pii/S002248041500949X http://hdl.handle.net/11452/31386 |
ISSN: | 0022-4804 1095-8673 |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.